Digestive & Intestinal Remedies (Pharmacies) - Zimbabwe

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$7.45m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -4.00%, resulting in a market volume of US$6.07m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$0.44 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Zimbabwe is experiencing steady growth due to customer preferences for natural and herbal remedies, as well as an increasing awareness of digestive health issues.

Customer preferences: Customers in Zimbabwe are increasingly seeking natural and herbal remedies for digestive and intestinal issues. This preference is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic treatment options. Additionally, customers are placing a greater emphasis on preventive healthcare and are seeking products that can promote overall digestive health.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Zimbabwe is the rising demand for probiotic supplements. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help to restore the natural balance of bacteria in the gut and promote healthy digestion. As customers become more aware of the importance of gut health, the demand for probiotic supplements is expected to continue to rise. Another trend in the market is the increasing popularity of herbal remedies. Zimbabwe has a rich tradition of herbal medicine, and customers are turning to traditional remedies for digestive and intestinal issues. Herbs such as ginger, peppermint, and aloe vera are believed to have beneficial effects on digestion and are commonly used to treat digestive ailments.

Local special circumstances: Zimbabwe has a high prevalence of digestive health issues, including gastrointestinal infections and diseases such as cholera and typhoid. This has led to an increased demand for digestive and intestinal remedies in the country. Additionally, the country has a large population of older adults who are more susceptible to digestive problems. This demographic factor further contributes to the demand for remedies in the market.

Underlying macroeconomic factors: Zimbabwe has been facing economic challenges in recent years, including high inflation and currency instability. These factors have impacted the affordability of healthcare products, including digestive and intestinal remedies. As a result, customers may be more inclined to seek cost-effective alternatives or rely on traditional remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Zimbabwe is driven by customer preferences for natural and herbal remedies, as well as an increasing awareness of digestive health issues. The demand for probiotic supplements and herbal remedies is on the rise, and the country's high prevalence of digestive health issues further contributes to the market growth. However, economic challenges may impact the affordability of these remedies for some customers.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.